P11047 (LAMC1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 156.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Laminin subunit gamma-1 Alternative name(s): Laminin B2 chain Laminin-1 subunit gamma Laminin-10 subunit gamma Laminin-11 subunit gamma Laminin-2 subunit gamma Laminin-3 subunit gamma Laminin-4 subunit gamma Laminin-6 subunit gamma Laminin-7 subunit gamma Laminin-8 subunit gamma Laminin-9 subunit gamma S-laminin subunit gamma Short name=S-LAM gamma | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1609 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
| Subunit structure | Laminin is a complex glycoprotein, consisting of three different polypeptide chains (alpha, beta, gamma), which are bound to each other by disulfide bonds into a cross-shaped molecule comprising one long and three short arms with globules at each end. Gamma-1 is a subunit of laminin-1 (laminin-111 or EHS laminin), laminin-2 (laminin-211 or merosin), laminin-3 (laminin-121 or S-laminin), laminin-4 (laminin-221 or S-merosin), laminin-6 (laminin-311 or K-laminin), laminin-7 (laminin-321 or KS-laminin), laminin-8 (laminin-411), laminin-9 (laminin-421), laminin-10 (laminin-511) and laminin-11 (laminin-521). |
| Subcellular location | Secreted › extracellular space › extracellular matrix › basement membrane. |
| Tissue specificity | Found in the basement membranes (major component). |
| Domain | The alpha-helical domains I and II are thought to interact with other laminin chains to form a coiled coil structure. Domains VI and IV are globular. |
| Sequence similarities | Contains 11 laminin EGF-like domains. Contains 1 laminin IV type A domain. Contains 1 laminin N-terminal domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 33 | 33 | |||||||||
| Chain | 34 – 1609 | 1576 | Laminin subunit gamma-1 | PRO_0000017074 | |||||||
Regions | |||||||||||
| Domain | 46 – 285 | 240 | Laminin N-terminal | ||||||||
| Domain | 286 – 341 | 56 | Laminin EGF-like 1 | ||||||||
| Domain | 342 – 397 | 56 | Laminin EGF-like 2 | ||||||||
| Domain | 398 – 444 | 47 | Laminin EGF-like 3 | ||||||||
| Domain | 445 – 494 | 50 | Laminin EGF-like 4 | ||||||||
| Domain | 495 – 504 | 10 | Laminin EGF-like 5; first part | ||||||||
| Domain | 514 – 689 | 176 | Laminin IV type A | ||||||||
| Domain | 690 – 723 | 34 | Laminin EGF-like 5; second part | ||||||||
| Domain | 724 – 772 | 49 | Laminin EGF-like 6 | ||||||||
| Domain | 773 – 827 | 55 | Laminin EGF-like 7 | ||||||||
| Domain | 828 – 883 | 56 | Laminin EGF-like 8 | ||||||||
| Domain | 884 – 934 | 51 | Laminin EGF-like 9 | ||||||||
| Domain | 935 – 982 | 48 | Laminin EGF-like 10 | ||||||||
| Domain | 983 – 1030 | 48 | Laminin EGF-like 11 | ||||||||
| Region | 1030 – 1609 | 580 | Domain II and I | ||||||||
| Coiled coil | 1038 – 1609 | 572 | Potential | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 1493 | 1 | Phosphoserine Ref.10 | ||||||||
| Glycosylation | 60 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 134 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 576 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 650 | 1 | N-linked (GlcNAc...) Ref.6 Ref.8 | ||||||||
| Glycosylation | 1022 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1107 | 1 | N-linked (GlcNAc...) Ref.7 Ref.8 | ||||||||
| Glycosylation | 1161 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 1175 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 1205 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1223 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||
| Glycosylation | 1241 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 1380 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1395 | 1 | N-linked (GlcNAc...) Ref.7 Ref.8 | ||||||||
| Glycosylation | 1439 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 286 ↔ 295 | By similarity | |||||||||
| Disulfide bond | 288 ↔ 305 | By similarity | |||||||||
| Disulfide bond | 307 ↔ 316 | By similarity | |||||||||
| Disulfide bond | 319 ↔ 339 | By similarity | |||||||||
| Disulfide bond | 342 ↔ 351 | By similarity | |||||||||
| Disulfide bond | 344 ↔ 367 | By similarity | |||||||||
| Disulfide bond | 370 ↔ 379 | By similarity | |||||||||
| Disulfide bond | 382 ↔ 395 | By similarity | |||||||||
| Disulfide bond | 398 ↔ 410 | By similarity | |||||||||
| Disulfide bond | 400 ↔ 416 | By similarity | |||||||||
| Disulfide bond | 418 ↔ 427 | By similarity | |||||||||
| Disulfide bond | 430 ↔ 442 | By similarity | |||||||||
| Disulfide bond | 445 ↔ 456 | By similarity | |||||||||
| Disulfide bond | 447 ↔ 463 | By similarity | |||||||||
| Disulfide bond | 465 ↔ 474 | By similarity | |||||||||
| Disulfide bond | 477 ↔ 492 | By similarity | |||||||||
| Disulfide bond | 724 ↔ 733 | By similarity | |||||||||
| Disulfide bond | 726 ↔ 740 | By similarity | |||||||||
| Disulfide bond | 742 ↔ 751 | By similarity | |||||||||
| Disulfide bond | 754 ↔ 770 | By similarity | |||||||||
| Disulfide bond | 773 ↔ 781 | By similarity | |||||||||
| Disulfide bond | 775 ↔ 792 | By similarity | |||||||||
| Disulfide bond | 795 ↔ 804 | By similarity | |||||||||
| Disulfide bond | 807 ↔ 825 | By similarity | |||||||||
| Disulfide bond | 828 ↔ 842 | By similarity | |||||||||
| Disulfide bond | 830 ↔ 849 | By similarity | |||||||||
| Disulfide bond | 852 ↔ 861 | By similarity | |||||||||
| Disulfide bond | 864 ↔ 881 | By similarity | |||||||||
| Disulfide bond | 884 ↔ 898 | By similarity | |||||||||
| Disulfide bond | 886 ↔ 905 | By similarity | |||||||||
| Disulfide bond | 907 ↔ 916 | By similarity | |||||||||
| Disulfide bond | 919 ↔ 932 | By similarity | |||||||||
| Disulfide bond | 935 ↔ 947 | By similarity | |||||||||
| Disulfide bond | 937 ↔ 954 | By similarity | |||||||||
| Disulfide bond | 956 ↔ 965 | By similarity | |||||||||
| Disulfide bond | 968 ↔ 980 | By similarity | |||||||||
| Disulfide bond | 983 ↔ 995 | By similarity | |||||||||
| Disulfide bond | 985 ↔ 1001 | By similarity | |||||||||
| Disulfide bond | 1003 ↔ 1012 | By similarity | |||||||||
| Disulfide bond | 1015 ↔ 1028 | By similarity | |||||||||
| Disulfide bond | 1031 | Interchain Probable | |||||||||
| Disulfide bond | 1034 | Interchain Probable | |||||||||
| Disulfide bond | 1600 | Interchain Probable | |||||||||
Natural variations | |||||||||||
| Natural variant | 458 | 1 | I → V. Ref.1 Ref.2 Corresponds to variant rs20563 [ dbSNP | Ensembl ]. | VAR_014700 | |||||||
| Natural variant | 731 | 1 | E → K. Corresponds to variant rs2230157 [ dbSNP | Ensembl ]. | VAR_054488 | |||||||
| Natural variant | 888 | 1 | L → P. Ref.1 Ref.2 Corresponds to variant rs20558 [ dbSNP | Ensembl ]. | VAR_014701 | |||||||
| Natural variant | 1116 | 1 | R → H in a colorectal cancer sample; somatic mutation. Ref.11 | VAR_035821 | |||||||
| Natural variant | 1121 | 1 | R → Q. Corresponds to variant rs20559 [ dbSNP | Ensembl ]. | VAR_014702 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 212 | 1 | I → F in AAA59492. Ref.2 | ||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human laminin B2 chain. Comparison of the complete amino acid sequence with the B1 chain reveals variability in sequence homology between different structural domains." Pikkarainen T., Kallunki T., Tryggvason K. J. Biol. Chem. 263:6751-6758(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS VAL-458 AND PRO-888. |
| [2] | "Structure of the human laminin B2 chain gene reveals extensive divergence from the laminin B1 chain gene." Kallunki T., Ikonen J., Chow L.T., Kallunki P., Tryggvason K. J. Biol. Chem. 266:221-228(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS VAL-458 AND PRO-888. |
| [3] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Differences in human laminin B2 sequences." Santos C.L.S., Sabbaga J., Brentani R. DNA Seq. 1:275-277(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1282-1609. Tissue: Endothelial cell. |
| [5] | "Isolation of a human laminin B2 (LAMB2) cDNA clone and assignment of the gene to chromosome region 1q25-->q31." Fukushima Y., Pikkarainen T., Kallunki T., Eddy R.L., Byers M.G., Haley L.L., Henry W.M., Tryggvason K., Shows T.B. Cytogenet. Cell Genet. 48:137-141(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1393-1609. |
| [6] | "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry." Zhang H., Li X.-J., Martin D.B., Aebersold R. Nat. Biotechnol. 21:660-666(2003) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT ASN-650. |
| [7] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1107; ASN-1161; ASN-1175; ASN-1223 AND ASN-1395, MASS SPECTROMETRY. Tissue: Plasma. |
| [8] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-650; ASN-1107; ASN-1241 AND ASN-1395, MASS SPECTROMETRY. Tissue: Liver. |
| [9] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [10] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1493, MASS SPECTROMETRY. |
| [11] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] HIS-1116. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | J03202 mRNA. Translation: AAA59488.1. M55210 M55209 Genomic DNA. Translation: AAA59492.1.AL354953, AL450304 Genomic DNA. Translation: CAH70981.1. AL450304, AL354953 Genomic DNA. Translation: CAI14877.1. X13939 mRNA. Translation: CAA32122.1. M27654 mRNA. Translation: AAA59489.1. |
| IPI | IPI00298281. |
| PIR | MMHUB2. S13548. |
| RefSeq | NP_002284.3. NM_002293.3. |
| UniGene | Hs.609663. |
3D structure databases | |
| ProteinModelPortal | P11047. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P11047. 5 interactions. |
| MINT | MINT-1184520. |
| STRING | 9606.ENSP00000258341. |
PTM databases | |
| PhosphoSite | P11047. |
Polymorphism databases | |
| DMDM | 224471885. |
Proteomic databases | |
| PaxDb | P11047. |
| PRIDE | P11047. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000258341; ENSP00000258341; ENSG00000135862. |
| GeneID | 3915. |
| KEGG | hsa:3915. |
| UCSC | uc001gpy.4. human. |
Organism-specific databases | |
| CTD | 3915. |
| GeneCards | GC01P182992. |
| H-InvDB | HIX0001405. |
| HGNC | HGNC:6492. LAMC1. |
| HPA | CAB004486. HPA001908. HPA001909. |
| MIM | 150290. gene. |
| neXtProt | NX_P11047. |
| PharmGKB | PA30280. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG235720. |
| HOGENOM | HOG000019301. |
| HOVERGEN | HBG100808. |
| InParanoid | P11047. |
| KO | K05635. |
| OMA | EATDYPW. |
| OrthoDB | EOG49GKFS. |
| PhylomeDB | P11047. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | smad2_3nuclearpathway. Regulation of nuclear SMAD2/3 signaling. |
| Reactome | REACT_111045. Developmental Biology. REACT_111102. Signal Transduction. |
Gene expression databases | |
| Bgee | P11047. |
| CleanEx | HS_LAMB2. HS_LAMC1. |
| Genevestigator | P11047. |
| GermOnline | ENSG00000135862. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR013032. EGF-like_CS. IPR002049. EGF_laminin. IPR018031. Laminin_B_subgr. IPR000034. Laminin_B_type_IV. IPR008211. Laminin_N. [Graphical view] |
| Pfam | PF00052. Laminin_B. 1 hit. PF00053. Laminin_EGF. 10 hits. PF00055. Laminin_N. 1 hit. [Graphical view] |
| SMART | SM00180. EGF_Lam. 10 hits. SM00281. LamB. 1 hit. SM00136. LamNT. 1 hit. [Graphical view] |
| PROSITE | PS00022. EGF_1. 8 hits. PS01186. EGF_2. 2 hits. PS01248. EGF_LAM_1. 11 hits. PS50027. EGF_LAM_2. 10 hits. PS51115. LAMININ_IVA. 1 hit. PS51117. LAMININ_NTER. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | LAMC1. human. |
| DrugBank | DB00009. Alteplase. DB00029. Anistreplase. DB00015. Reteplase. DB00031. Tenecteplase. |
| GenomeRNAi | 3915. |
| NextBio | 15381. |
| SOURCE | Search... |
Entry information
| Entry name | LAMC1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P11047 Secondary accession number(s): Q5VYE7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
